相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。High coexpression of both insulin-like growth factor receptor-1 (IGFR-1) and epidermal growth factor receptor (EGFR) is associated with shorter disease-free survival in resected non-small-cell lung cancer patients
V. Ludovini et al.
ANNALS OF ONCOLOGY (2009)
An E2F1-dependent gene expression program that determines the balance between proliferation and cell death
Timothy C. Hallstrom et al.
CANCER CELL (2008)
Bypassing cellular EGF receptor dependence through epithelial-to-mesenchymal-like transitions
Sharon Barr et al.
CLINICAL & EXPERIMENTAL METASTASIS (2008)
Transcriptional Repression of the Prosurvival Endoplasmic Reticulum Chaperone GRP78/BIP by E2F1
Tomas Racek et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
The role of the EGFR signaling in tumor microenvironment
Antonella De Luca et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2008)
E2F-1, Skp2 and cyclin E oncoproteins are upregulated and directly correlated in high-grade neuroendocrine lung tumors
C. Salon et al.
ONCOGENE (2007)
Therapeutic window for melanoma treatment provided by selective effects of the proteasome on Bcl-2 proteins
K. G. Wolter et al.
CELL DEATH AND DIFFERENTIATION (2007)
Transcriptional profiling identifies cyclin D1 as a critical downstream effector of mutant epidermal growth factor receptor signaling
Susumu Kobayashi et al.
CANCER RESEARCH (2006)
E2F1 induces MRN foci formation and a cell cycle checkpoint response in human fibroblasts
F. M. Frame et al.
ONCOGENE (2006)
Increased gene copy number of the transcription factor E2F1 in malignant melanoma
MA Nelson et al.
CANCER BIOLOGY & THERAPY (2006)
EGF-induced cell migration is mediated by ERK and PI3K/AKT pathways in cultured human lens epithelial cells
Q Jiang et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2006)
Rb inactivation leads to E2F1-mediated DNA double-strand break accumulation
MT Pickering et al.
ONCOGENE (2006)
Nuclear EGFR signalling network in cancers: linking EGFR pathway to cell cycle progression, nitric oxide pathway and patient survival
HW Lo et al.
BRITISH JOURNAL OF CANCER (2006)
C-terminal p73 isoforms repress transcriptional activity of the human telomerase reverse transcriptase (hTERT) promoter
T Racek et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Molecular requirements for epithelial-mesenchymal transition during tumor progression
MA Huber et al.
CURRENT OPINION IN CELL BIOLOGY (2005)
Differential regulation of noxa in normal Melanocytes and melanoma cells by proteasome inhibition:: Therapeutic implications
Y Fernández et al.
CANCER RESEARCH (2005)
Overexpression of E2F1 in lung and liver metastases of human colon cancer is associated with gene amplification
M Iwamoto et al.
CANCER BIOLOGY & THERAPY (2004)
Distinct expression patterns of the transcription factor E2F-1 in relation to tumour growth parameters in common human carcinomas
P Zacharatos et al.
JOURNAL OF PATHOLOGY (2004)
Alterations of Delta TA-p73 splice transcripts during melanoma development and progression
S Tuve et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Up-regulation of transcriptional factor E2F1 in papillary and anaplastic thyroid cancers
M Onda et al.
JOURNAL OF HUMAN GENETICS (2004)
Overexpression of E2F1 associated with LOH at RB locus and hyperphosphorylation of RB in non-small cell lung carcinoma
MA Imai et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2004)
Constitutive E2F1 overexpression delays endochondral bone formation by inhibiting chondrocyte differentiation
B Scheijen et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
E2F1 expression is related with the poor survival of lymph node-positive breast cancer patients treated with fluorouracil, doxorubicin and cyclophosphamide
S Han et al.
BREAST CANCER RESEARCH AND TREATMENT (2003)
Expression of transcription factor E2F-1 in pancreatic ductal carcinoma: An immunohistochemical study
K Yamazaki et al.
PATHOLOGY RESEARCH AND PRACTICE (2003)
Apaf-1 is a mediator of E2F-1-induced apoptosis
Y Furukawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Lmmunohistochemical expression of cyclin D1, E2F-1, and Xi-67 in benign and malignant thyroid lesions
AD Saiz et al.
JOURNAL OF PATHOLOGY (2002)
Transcription factor E2F-1 acts as a growth-promoting factor and is associated with adverse prognosis in non-small cell lung carcinomas
VG Gorgoulis et al.
JOURNAL OF PATHOLOGY (2002)
Epithelial-mesenchymal transitions in tumour progression
JP Thiery
NATURE REVIEWS CANCER (2002)
Distinct pattern of E2F1 expression in human lung tumours: E2F1 is upregulated in small cell lung carcinoma
B Eymin et al.
ONCOGENE (2001)
Inactivation of the apoptosis effector Apaf-1 in malignant melanoma
MS Soengas et al.
NATURE (2001)
Role of the p53-homologue p73 in EZF1-induced apoptosis
T Stiewe et al.
NATURE GENETICS (2000)
Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis
EA Conner et al.
ONCOGENE (2000)
E2F-1 induces proliferation-specific genes and suppresses squamous differentiation-specific genes in human epidermal keratinocytes
AJ Dicker et al.
ONCOGENE (2000)
E2F4 and E2F1 have similar proliferative properties but different apoptotic and oncogenic properties in vivo
DW Wang et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Deregulated E2F transcriptional activity in autonomously growing melanoma cells
R Halaban et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Rb function in cell-cycle regulation and apoptosis
JW Harbour et al.
NATURE CELL BIOLOGY (2000)